Search
for
Sort by
Research 361–390 of 1000+
- Transcriptome Analysis Reveals Skin Lipid Metabolism Related to Wool Diameter in Sheep
- Microglia Stimulate Zebrafish Brain Repair Via a Tumor Necrosis Factor-<i>α</i>-Initiated Inflammatory Cascade
- Human melanocyte development and melanoma dedifferentiation at single cell resolution
- Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection – results of a prospective multicenter cohort
- Risk factors associated with development and persistence of long COVID
- Clomipramine suppresses ACE2-mediated SARS-CoV-2 entry
- Skin-resident immune cells actively coordinate their distribution with epidermal cells during homeostasis
- A computational modelling framework to quantify the effects of passaging cell lines
- Developmental Genetics of Color Pattern Establishment in Cats
- An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
- Haplotypes spanning centromeric regions reveal persistence of large blocks of archaic DNA
- The G1/S transition in mammalian stem cells<i>in vivo</i>is autonomously regulated by cell size
- The Microanatomy of Human Skin in Aging
- Three-dimensional reconstructions of mechanosensory end organs suggest a unifying mechanism underlying dynamic, light touch
- Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)
- Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- A Wnt5a-Cdc42 axis controls aging and rejuvenation of hair-follicle stem cells
- Single cell transcriptomics of human epidermis reveals basal stem cell transition states
- Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin
- 3D cell culture stimulates the secretion of in vivo like extracellular vesicles
- Genetic Prediction of Male Pattern Baldness
- GENOME REPORT: Chromosome-scale genome assembly of the African spiny mouse (<i>Acomys cahirinus</i>)
- The heme-responsive PrrH sRNA regulates<i>Pseudomonas aeruginosa</i>pyochelin gene expression
- G2 stem cells orchestrate time-directed, long-range coordination of calcium signaling during skin epidermal regeneration
- The BLMP-1 transcription factor promotes oscillatory gene expression to achieve timely molting
- Post-acute COVID-19 syndrome and its prolonged effects: An updated systematic review
- Visualization of individual cell division history in complex tissues
- Differential risk for COVID-19 in the first wave of the disease (February-April 2020) among migrants from several areas of the world living in Alcorcón (Spain): A population-based cohort study